Nucleic Acids in   Canada

Overview In December 2024 Canada's Nucleic Acids exports accounted up to C$1.59M and imports accounted up to C$185M, resulting in a negative trade balance of C$183M. Between December 2023 and December 2024 the exports of Canada's   Nucleic Acids have decreased by C$-1.03M (-39.4%) from C$2.62M to C$1.59M, while imports increased by C$163M (755%) from C$21.6M to C$185M.

Destinations In December 2024, Nucleic Acids were exported mostly to Spain (C$693k), United States (C$576k), Germany (C$113k), France (C$55.5k), and South Korea (C$47.5k), and were imported mostly from Switzerland (C$129M), United States (C$21.3M), China (C$15M), Sweden (C$5.09M), and India (C$4.53M).

Growth In December 2024, the decrease in Nucleic Acids's year-by-year exports was explained primarily by a decrease in exports to France (C$-3.61M or -99.9%), United States (C$-1.52M or -89%), and Italy (C$-15.3k or -90.1%). In December 2024, the increase in Nucleic Acids's year-by-year imports was explained primarily by an increase in imports from South Korea (C$4.54M or 244%), China (C$3.38M or 57.4%), and United States (C$3.14M or 81.7%).